Skip to content

Astrana 医疗

US · ASTH #2768 按市值排名 上市于 1970
36.81 -1.22 -3.21%
实时 - 追踪5344个代码 - 心跳于5秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

减持
  • 最近一期（2026/Q3）披露持股的机构数量增加了1家。
  • 机构持股总比例下降了2.9个百分点。

机构持股

机构持股比例
76.71% -2.92pp
机构数量
256 +1
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund54.22%
Private Company13.88%
Individual/Insider10.73%
Hedge Fund4.75%
Public Company2.51%
Government Pension Fund1.09%
Family Office/Trust0.17%
Other12.58%

主要股东 截至 2026-06-30

BlackRock 13.48% · 6.90M 股
Allied Physicians of California IPA 13.35% · 6.83M 股
Vanguard Portfolio Management, LLC 5.09% · 2.61M 股
Vanguard Capital Management, LLC 4.40% · 2.25M 股
Brandon Sim 3.69% · 1.89M 股
State Street Global Advisors 3.40% · 1.74M 股
325 Capital, LLC 3.15% · 1.61M 股
Thomas Lam 3.04% · 1.56M 股
Dimensional Fund Advisors 2.87% · 1.47M 股
Kenneth Sim 2.85% · 1.46M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 20次买入 · 28次卖出

姓名职务持股比例
Brandon Sim Co-Chief Executive Officer 3.69%
Thomas Lam President, Co-CEO & Director 3.04%
Kenneth Sim Executive Chairperson 2.85%
Chandan Basho Chief Strategy Officer, CFO & Corporate Secretary 0.31%
Dinesh Kumar Chief Medical Officer 0.31%
Linda Dong Director 0.19%
Matthew Mazdyasni Director 0.08%
David Schmidt Independent Director 0.07%
John Chiang Independent Director 0.07%
Mitchell Kitayama Lead Independent Director 0.05%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-14 John Vong Chief Accounting Officer Sale to Issuer -96 $38.35
2026-09-04 Brandon Sim Co-Chief Executive Officer Sale to Issuer -7,163 $38.47
2026-09-04 Chandan Basho Chief Strategy Officer, CFO & Corporate Secretary Sale to Issuer -1,790 $38.47
2026-08-30 Mitchell Kitayama Lead Independent Director Sale to Issuer -8,500 $37.09
2026-08-13 David Schmidt Independent Director Derivative Exercise and Sale -20,000 $5.00–38.59
2026-08-06 John Vong Chief Accounting Officer Initial Statement of Beneficial 0 --
2026-08-06 Glenn Sobotka Chief Accounting Officer Sale to Issuer -11,793 --
2026-06-26 Brandon Sim Co-Chief Executive Officer Sale to Issuer -1,093 $44.51
2026-06-09 Weili Dai Independent Director Other Acquisition +4,525 --
2026-06-09 Mitchell Kitayama Lead Independent Director Other Acquisition +4,991 --
2026-06-09 David Schmidt Independent Director Other Acquisition +4,525 --
2026-06-09 John Chiang Independent Director Other Acquisition +4,525 --
2026-06-09 Matthew Mazdyasni Director Other Acquisition +4,525 --
2026-06-09 Linda Dong Director Other Acquisition +4,525 --
2026-05-15 Chandan Basho Chief Strategy Officer, CFO & Corporate Secretary Sale to Issuer -8,155 $38.26
2026-04-13 Chandan Basho Chief Strategy Officer, CFO & Corporate Secretary Sale to Issuer -3,870 $29.07
2026-04-05 Thomas Lam President, Co-CEO & Director Other Acquisition +41,667 --
2026-04-05 Kenneth Sim Executive Chairperson Other Acquisition +100,000 --
2026-04-05 Brandon Sim Co-Chief Executive Officer Other Acquisition +201,056 --
2026-04-01 Chandan Basho Chief Strategy Officer, CFO & Corporate Secretary Sale to Issuer -2,092 $25.05

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

Astrana 医疗 讨论区 0 条评论

发表评论